This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ghannoum, M A
Right arrow Articles by Edwards, J E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ghannoum, M A
Right arrow Articles by Edwards, J E, Jr

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1992 October; 36(10): 2239-2244

Modulation of interactions of Candida albicans and endothelial cells by fluconazole and amphotericin B.

M A Ghannoum, S G Filler, A S Ibrahim, Y Fu and J E Edwards Jr

Department of Medicine, Harbor-University of California, Los Angeles Medical Center, Torrance 90509.

ABSTRACT

Using an in vitro model of intravascular infection, we examined the effects of exposure to subinhibitory concentrations of fluconazole and amphotericin B on the ability of Candida albicans to adhere to and damage human umbilical vein endothelial cells. Incubation of the organisms for 18 h in 0.5x the MICs of fluconazole and amphotericin B inhibited endothelial cell adherence by 22 and 91%, respectively (P less than 0.001 for each drug). Candida-induced endothelial cell injury was also decreased by exposing the organisms to the antifungal drugs while in contact with the endothelial cells. Fluconazole inhibited damage by approximately 50% at concentrations ranging from 0.25x to 5x the MIC (P less than 0.01 for each concentration). Exposure to amphotericin B at 0.5x the MIC completely blocked the ability of the organisms to injure endothelial cells. The capacities of the antifungal agents to inhibit endothelial cell injury paralleled their abilities to suppress candidal germination. Organisms exposed to up to 5x the MIC of fluconazole had diminished, but still detectable, germ tube production and elongation, whereas incubation in 0.5x the MIC of amphotericin B completely abrogated germination. In addition to their direct effects on the growth of C. albicans, fluconazole and amphotericin B may decrease the ability of the fungus to disseminate hematogenously by inhibiting the organisms' capacity to adhere to and injure endothelial cells.


Antimicrob Agents Chemother. 1992 October; 36(10): 2239-2244




This article has been cited by other articles:

  • Grubb, S. E. W., Murdoch, C., Sudbery, P. E., Saville, S. P., Lopez-Ribot, J. L., Thornhill, M. H. (2008). Candida albicans-Endothelial Cell Interactions: a Key Step in the Pathogenesis of Systemic Candidiasis. Infect. Immun. 76: 4370-4377 [Full Text]  
  • Mukherjee, P. K., Mohamed, S., Chandra, J., Kuhn, D., Liu, S., Antar, O. S., Munyon, R., Mitchell, A. P., Andes, D., Chance, M. R., Rouabhia, M., Ghannoum, M. A. (2006). Alcohol Dehydrogenase Restricts the Ability of the Pathogen Candida albicans To Form a Biofilm on Catheter Surfaces through an Ethanol-Based Mechanism. Infect. Immun. 74: 3804-3816 [Abstract] [Full Text]  
  • Kuhn, D. M., George, T., Chandra, J., Mukherjee, P. K., Ghannoum, M. A. (2002). Antifungal Susceptibility of Candida Biofilms: Unique Efficacy of Amphotericin B Lipid Formulations and Echinocandins. Antimicrob. Agents Chemother. 46: 1773-1780 [Abstract] [Full Text]  
  • Kaufman, D., Boyle, R., Hazen, K. C., Patrie, J. T., Robinson, M., Donowitz, L. G. (2001). Fluconazole Prophylaxis against Fungal Colonization and Infection in Preterm Infants. NEJM 345: 1660-1666 [Abstract] [Full Text]  
  • Davis, D., Edwards, J. E. Jr., Mitchell, A. P., Ibrahim, A. S. (2000). Candida albicans RIM101 pH Response Pathway Is Required for Host-Pathogen Interactions. Infect. Immun. 68: 5953-5959 [Abstract] [Full Text]  
  • Tsuchimori, N., Sharkey, L. L., Fonzi, W. A., French, S. W., Edwards, J. E. Jr., Filler, S. G. (2000). Reduced Virulence of HWP1-Deficient Mutants of Candida albicans and Their Interactions with Host Cells. Infect. Immun. 68: 1997-2002 [Abstract] [Full Text]  
  • Ghannoum, M. A. (2000). Potential Role of Phospholipases in Virulence and Fungal Pathogenesis. Clin. Microbiol. Rev. 13: 122-143 [Abstract] [Full Text]  
  • Rieg, G., Fu, Y., Ibrahim, A. S., Zhou, X., Filler, S. G., Edwards, J. E. Jr. (1999). Unanticipated Heterogeneity in Growth Rate and Virulence among Candida albicans AAF1 Null Mutants. Infect. Immun. 67: 3193-3198 [Abstract] [Full Text]  
  • Fu, Y., Filler, S. G., Spellberg, B. J., Fonzi, W., Ibrahim, A. S., Kanbe, T., Ghannoum, M. A., Edwards, J. E. Jr. (1998). Cloning and Characterization of CAD1/AAF1, a Gene from Candida albicans That Induces Adherence to Endothelial Cells after Expression in Saccharomyces cerevisiae. Infect. Immun. 66: 2078-2084 [Abstract] [Full Text]  
  • Fu, Y., Rieg, G., Fonzi, W. A., Belanger, P. H., Edwards, J. E. Jr., Filler, S. G. (1998). Expression of the Candida albicans Gene ALS1 in Saccharomyces cerevisiae Induces Adherence to Endothelial and Epithelial Cells. Infect. Immun. 66: 1783-1786 [Abstract] [Full Text]  
  • Cannon, R.D., Holmes, A.R., Mason, A.B., Monk, B.C. (1995). Oral Candida: Clearance, Colonization, or Candidiasis?. JDR 74: 1152-1161 [Abstract]